T

TheraBionic GmbH

2 employees

Company is focused on the commercialization of its first oncology application: treatment of advanced hepatocellular carcinoma

Basic info

Sectors

Biotechnology
Health Care

Date founded

2001

Funding rounds raised

Total raised

$40K

from 1 investors over 1 rounds

T

TheraBionic GmbH raised $40K on March 15, 2022

Investors: North Carolina Biotechnology Center (NCBiotech)

FAQ